Plant ID: NPO17675
Plant Latin Name: Andira inermis
Taxonomy Genus: Andira
Taxonomy Family: Fabaceae
NCBI TaxonomyDB:
53825
Plant-of-the-World-Online:
n.a.
Brazil; China
TSHR; | |
BLM; AOX1; | |
EGFR; | |
CA7; CA4; CA12; | |
ESR2; ESR1; | |
ESRRB; ESRRA; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Enzyme_unclassified | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Enzyme_unclassified | AOX1 | Aldehyde oxidase | Q06278 | CHEMBL3257 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Nuclear hormone receptor subfamily 3 group A | ESR2 | Estrogen receptor beta | Q92731 | CHEMBL242 |
Nuclear hormone receptor subfamily 3 group A | ESR1 | Estrogen receptor alpha | P03372 | CHEMBL206 |
Nuclear hormone receptor subfamily 3 group B | ESRRB | Estrogen-related receptor beta | O95718 | CHEMBL3751 |
Nuclear hormone receptor subfamily 3 group B | ESRRA | Estrogen-related receptor alpha | P11474 | CHEMBL3429 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Kinase | EGFR | Epidermal growth factor receptor erbB1 | P00533 | CHEMBL203 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 1.015E-08 | 1.106E-04 | BLM, CA12, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.078E-07 | 3.355E-04 | CA12, CA4, CA7 |
MF | GO:0005488; binding | GO:0005496; steroid binding | 2.540E-07 | 6.912E-04 | ESR1, ESR2, ESRRA, ESRRB |
MF | GO:0060089; molecular transducer activity | GO:0038052; RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | 4.181E-07 | 1.012E-03 | ESR1, ESR2 |
BP | GO:0009987; cellular process | GO:0043401; steroid hormone mediated signaling pathway | 1.336E-06 | 2.910E-03 | ESR1, ESR2, ESRRA, ESRRB |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 1.679E-06 | 3.323E-03 | CA12, CA4, CA7 |
MF | GO:0005488; binding | GO:0034056; estrogen response element binding | 2.507E-06 | 4.101E-03 | ESR1, ESR2 |
BP | GO:0008152; metabolic process | GO:0006367; transcription initiation from RNA polymerase II promoter | 3.059E-06 | 4.224E-03 | ESR1, ESR2, ESRRA, ESRRB |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 3.104E-06 | 4.224E-03 | CA12, CA4, CA7 |
BP | GO:0009987; cellular process | GO:0030522; intracellular receptor signaling pathway | 4.367E-06 | 5.283E-03 | ESR1, ESR2, ESRRA, ESRRB |
MF | GO:0098772; molecular function regulator | GO:0030235; nitric-oxide synthase regulator activity | 8.764E-06 | 9.088E-03 | EGFR, ESR1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 1.451E-07 | 8.997E-06 | CA12, CA4, CA7 |
09150 Organismal Systems | 09152 Endocrine system | hsa04915 | Estrogen signaling pathway | 3.246E-05 | 1.006E-03 | ESR1, EGFR, ESR2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
N00-N99: Diseases of the genitourinary system | Prostate disease | N42.9 | CYP19A1; |
H00-H59: Diseases of the eye and adnexa | Ocular hypertension | H40.0 | CA4; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA4; |
C00-D49: Neoplasms | Advanced breast cancer | C50 | CYP19A1; |
C00-D49: Neoplasms | Bladder cancer | C67 | CYP19A1; |
C00-D49: Neoplasms | Breast cancer | C50 | CYP19A1; |
N00-N99: Diseases of the genitourinary system | Endometriosis | N80 | CYP19A1; |
C00-D49: Neoplasms | Hormonally-responsive breast cancer | C50 | CYP19A1; |